Consensus Nanobiotix

Equities

NANO

FR0011341205

Market Closed - Euronext Paris Other stock markets 11:35:04 2024-04-24 am EDT			After market 02:02:50 pm
5.535 ^EUR	-3.74%		5.543	+0.14%

Apr. 03	Nanobiotix completes escalation portion of 2020-0123 study	CF
Apr. 02	Nanobiotix Completes Dose Escalation Segment of Phase 1 Study Targeting Non-Small Cell Lung Cancer	MT

Evolution of the average Target Price on Nanobiotix

Price target over the last 5 years

History of analyst recommendation changes

b6df6e45499353.LT9VsRykGBCoX21JEI3SgdsL9367ue46yOuNQUy8TxQ.e14f5XLBcHfpCB4TWMWm65lGhyj5jo10obP4Jj33JmJ7dnjEKfxAYt0TBg~ee920cf422fb8f84cdcca0d3795f17b5

Analyst Recommendations on Nanobiotix

But where have the bears gone?	Nov. 03
The Fed doesn't want to raise rates (but is pretending to)	Nov. 02
NANOBIOTIX S A : Evercore ISI Starts Nanobiotix at Outperform	21-01-06	MT